/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $63.8 billion, Cencora, Inc. (COR) is a leading global healthcare solutions provider. The company sources and distributes pharmaceutical and healthcare products while offering a wide range of logistics, data analytics, and commercialization services to healthcare providers and manufacturers worldwide.
The Conshohocken, Pennsylvania-based company is slated to announce its fiscal Q4 2025 results before the market opens on Wednesday, Nov. 5. Ahead of the event, analysts forecast Cencora to report an adjusted EPS of $3.79, up 13.5% from $3.34 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarterly reports.